Covered recipient · General Payments record
DAVID E MILKES
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$15,410.27
- Reported across 1,188 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,296.21 | 161 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $20.00 | 1 |
| Education | $18.93 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $491.47 | 48 |
| Janssen Biotech, Inc. | $375.31 | 21 |
| PFIZER INC. | $273.10 | 14 |
| Lilly USA, LLC | $243.52 | 18 |
| Celgene Corporation | $211.80 | 19 |
| Ardelyx, Inc. | $133.03 | 12 |
| Phathom Pharmaceuticals, Inc. | $115.87 | 4 |
| Takeda Pharmaceuticals U.S.A., Inc. | $87.48 | 5 |
| Madrigal Pharmaceuticals | $72.56 | 4 |
| GENZYME CORPORATION | $50.02 | 2 |
| AIMMUNE THERAPEUTICS, INC. | $42.09 | 2 |
| INTERCEPT PHARMACEUTICALS, INC. | $41.25 | 2 |
| Celltrion USA Inc. | $35.80 | 2 |
| CapsoVision, Inc. | $34.14 | 2 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $28.95 | 2 |
| Gilead Sciences, Inc. | $22.47 | 1 |
| Braintree Laboratories, Inc. | $20.15 | 1 |
| RedHill Biopharma Inc. | $14.63 | 1 |
| Medtronic, Inc. | $14.56 | 1 |
| EVOKE PHARMA, INC. | $13.84 | 1 |
| Merck Sharp & Dohme Corporation | $13.10 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (163)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.